Hematology Oncology Associates of Central New York-Liverpool

Liverpool, New York 13088

0 studies enrolling now · 7 studies all time

What they study most

Advanced Adult Hepatocellular Carcinoma, Anemia, Chronic Lymphocytic Leukemia, Clear Cell Renal Cell Carcinoma, Colorectal Neoplasms, Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma, Lymphoma, Mantle Cell Lymphoma, Melanoma of Unknown Primary, Metastatic Kidney Carcinoma

Studies at this site

• Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery — Running, not enrolling
• Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Running, not enrolling
• Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer — Completed
• Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma — Running, not enrolling
• S0820, Adenoma and Second Primary Prevention Trial — Running, not enrolling
• Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors — Completed
• Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer — Completed